Pastāsti draugiem par šo preci:
Innovations for Next-Generation Antibody-Drug Conjugates - Cancer Drug Discovery and Development 2018 edition
Innovations for Next-Generation Antibody-Drug Conjugates - Cancer Drug Discovery and Development
While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.
357 pages, 52 Illustrations, color; 18 Illustrations, black and white; VIII, 357 p. 70 illus., 52 il
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2018. gada 11. jūnijs |
| ISBN13 | 9783319781532 |
| Izdevēji | Springer International Publishing AG |
| Lapas | 357 |
| Izmēri | 150 × 220 × 20 mm · 689 g |
| Valoda | Vācu |
| Redaktors | Damelin, Marc |